IL112074A - Branched-amino-substituted thiazoles their preparation and pharmaceutical compositions containing them - Google Patents

Branched-amino-substituted thiazoles their preparation and pharmaceutical compositions containing them

Info

Publication number
IL112074A
IL112074A IL11207494A IL11207494A IL112074A IL 112074 A IL112074 A IL 112074A IL 11207494 A IL11207494 A IL 11207494A IL 11207494 A IL11207494 A IL 11207494A IL 112074 A IL112074 A IL 112074A
Authority
IL
Israel
Prior art keywords
radical
formula
carbon atoms
compounds
alkyl
Prior art date
Application number
IL11207494A
Other languages
English (en)
Other versions
IL112074A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL112074A0 publication Critical patent/IL112074A0/xx
Publication of IL112074A publication Critical patent/IL112074A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11207494A 1993-12-21 1994-12-20 Branched-amino-substituted thiazoles their preparation and pharmaceutical compositions containing them IL112074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315386A FR2714059B1 (fr) 1993-12-21 1993-12-21 Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
IL112074A0 IL112074A0 (en) 1995-03-15
IL112074A true IL112074A (en) 1998-12-06

Family

ID=9454174

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11207494A IL112074A (en) 1993-12-21 1994-12-20 Branched-amino-substituted thiazoles their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (2) US5602132A (de)
EP (1) EP0659747B1 (de)
JP (1) JP3022223B2 (de)
KR (1) KR950017980A (de)
CN (1) CN1058964C (de)
AT (1) ATE164578T1 (de)
AU (1) AU685876B2 (de)
CA (1) CA2138638A1 (de)
CZ (1) CZ323094A3 (de)
DE (1) DE69409337T2 (de)
DK (1) DK0659747T3 (de)
ES (1) ES2115904T3 (de)
FI (1) FI945975A7 (de)
FR (1) FR2714059B1 (de)
HU (1) HUT71103A (de)
IL (1) IL112074A (de)
NO (1) NO304598B1 (de)
NZ (1) NZ270229A (de)
PL (1) PL306402A1 (de)
RU (1) RU2107063C1 (de)
SI (1) SI0659747T1 (de)
TW (1) TW401410B (de)
ZA (1) ZA9410196B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2796380B3 (fr) * 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
KR20030016222A (ko) * 2000-02-14 2003-02-26 니뽄 다바코 산교 가부시키가이샤 수술후 스트레스 예방ㆍ치료제
EP1149583A3 (de) * 2000-04-13 2001-11-14 Pfizer Products Inc. Kombinationen bestehend aus Antagonisten des Corticotropin freisetzenden Faktors und Stoffen, die die Wachstumshormonsekretion fördern
HUP0303038A2 (hu) * 2000-09-21 2003-12-29 Bristol-Myers Squibb Co. Szubsztituált azolszármazékok mint kortikotropin releasing faktor inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
PL214231B1 (pl) 2001-04-27 2013-07-31 Eisai R & D Man Co Pochodne pirazolo [1,5-a] pirydyny, kompozycje je zawierajace oraz zastosowanie
EP1423113A4 (de) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag Nr1h4-nuklearrezeptorbindende verbindungen
EP1285914B1 (de) * 2001-08-13 2007-12-19 PheneX Pharmaceuticals AG Nr1h4-kern-rezeptor-bindende verbindungen
US6818663B2 (en) * 2002-05-17 2004-11-16 Hoffmann-La Roches Diaminothiazoles
EP1513547A4 (de) * 2002-05-23 2009-11-04 Michael F Holick Verwendung von parathormone-peptid-analoga zur behandlung von scheidenatrophie
KR100984085B1 (ko) 2002-10-22 2010-09-30 에자이 알앤드디 매니지먼트 가부시키가이샤 7-페닐 피라졸로피리딘 화합물
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
US7211576B2 (en) * 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
AR057661A1 (es) * 2005-07-11 2007-12-12 Tanabe Seiyaku Co Un derivado de oxima y sus preparaciones
SI2266990T1 (sl) 2008-04-15 2013-01-31 Eisai R&D Management Co. Ltd. Spojina 3-fenilpirazolo(5,1-b)tiazola
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
JPWO2011043387A1 (ja) * 2009-10-08 2013-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロオキサゾール化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299087A (en) * 1961-04-24 1967-01-17 Geigy Chem Corp Nu, nu'-bis-(thiazolyl)-phenylenediamines
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US5232921A (en) * 1987-03-12 1993-08-03 Sanofi Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
DE3923675A1 (de) * 1989-07-18 1991-01-24 Basf Ag Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CN1127252A (zh) 1996-07-24
AU8163294A (en) 1995-06-29
FR2714059B1 (fr) 1996-03-08
FR2714059A1 (fr) 1995-06-23
JPH07224051A (ja) 1995-08-22
CZ323094A3 (en) 1995-07-12
HU9403690D0 (en) 1995-02-28
US5602132A (en) 1997-02-11
IL112074A0 (en) 1995-03-15
US5821255A (en) 1998-10-13
NO944946L (no) 1995-06-22
CN1058964C (zh) 2000-11-29
FI945975L (fi) 1995-06-22
TW401410B (en) 2000-08-11
JP3022223B2 (ja) 2000-03-15
AU685876B2 (en) 1998-01-29
FI945975A7 (fi) 1995-06-22
ATE164578T1 (de) 1998-04-15
CA2138638A1 (en) 1995-06-22
NZ270229A (en) 1996-04-26
HUT71103A (en) 1995-11-28
RU2107063C1 (ru) 1998-03-20
ZA9410196B (en) 1996-06-21
DE69409337D1 (de) 1998-05-07
DE69409337T2 (de) 1998-10-08
NO304598B1 (no) 1999-01-18
EP0659747B1 (de) 1998-04-01
ES2115904T3 (es) 1998-07-01
EP0659747A1 (de) 1995-06-28
SI0659747T1 (en) 1998-08-31
DK0659747T3 (da) 1999-01-11
FI945975A0 (fi) 1994-12-20
PL306402A1 (en) 1995-06-26
NO944946D0 (no) 1994-12-20
RU94044534A (ru) 1996-10-27
KR950017980A (ko) 1995-07-22

Similar Documents

Publication Publication Date Title
US4725610A (en) Thiazolidinedione derivatives, their production and use
AU685876B2 (en) Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
JP3884290B2 (ja) Hpparアルファアクチベーターとしての置換オキサゾールおよびチアゾール誘導体
NZ247949A (en) Branched alkylamino derivatives of thiazole, preparation and pharmaceutical compositions thereof
EP1300401B1 (de) Thiazol-derivate zur verwendung als entzündungshemmende mittel
US4560690A (en) 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
CZ20033250A3 (en) Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
CA2664301A1 (en) Fused ring compounds for inflammation and immune-related uses
NO811462L (no) Fremgangsmaate ved fremstilling av aminothiadiazoler
CA2195559A1 (en) Thiazolidinedione derivatives, their production and use
US20100048891A1 (en) Metasubstituted thiazolidinones, their manufacture and use as a drug
JP2004517100A (ja) hPPARアルファアゴニストとしての置換オキサゾールおよびチアゾール
NO324352B1 (no) Aminotiazolderivater, fremgangsmate for deres fremstilling, deres anvendelse samt farmasoytisk preparat
EP1874765A2 (de) Harnstoffderivate, verfahren zu ihrer herstellung und ihre anwendungen
JPH11503121A (ja) アミジン誘導体
AU2004207658B2 (en) Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
WO1999033827A1 (en) Novel imidazole derivatives
IL95053A (en) 2-Amino-3-Alkylbenzothiazolines are converted, their preparation and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees